EUVIMEDEUVIMED entdecken
Crossref

Pattern of Cutaneous Adverse Drug Reactions reported at a Tertiary Care Hospital in Southern Rajasthan: A Descriptive Study

Meena Atray, Arjun Sanjaykumar Mody, Vishwa Mehta

International Journal of Pharmaceutical Quality Assurance · 30.06.2026 · 17 (06)

DOI: 10.25258/ijpqa.17.6.29 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.06.2026. Verfasst von Meena Atray und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cutaneous adverse drug reactions (CADRs) are among the most frequently encountered adverse drug reactions and represent an important challenge in clinical practice and pharmacovigilance. They range from mild self-limiting eruptions to severe life-threatening conditions, contributing significantly to patient morbidity and healthcare burden. Monitoring the pattern and causative agents of CADRs is essential for improving patient safety and promoting rational drug use.

Aim

To evaluate the pattern, causality, severity, and outcomes of cutaneous adverse drug reactions reported at a tertiary care teaching hospital in Southern Rajasthan.

Methods

This retrospective observational study was conducted at a tertiary care teaching hospital in Southern Rajasthan. All suspected CADRs reported by the Department of Dermatology between January 2023 and December 2025 under the Pharmacovigilance Programme of India (PvPI) were analysed. Incomplete reports were excluded. Data regarding demographic profile, clinical presentation, suspected drugs, severity, outcomes, and causality assessment were collected and analysed using descriptive statistics. Causality assessment was performed using the WHO–UMC causality assessment scale.

Results

A total of 127 CADR reports were analysed. The majority of patients belonged to the 21–40 years age group (43.5%), with male predominance (55.2%). Fixed drug eruption was the most commonly reported CADR (43.3%), followed by hyperpigmented patches, urticaria, erythematous plaques, and maculopapular rashes. Ofloxacin (37.0%) and ornidazole (34.6%) were the most frequently implicated drugs, followed by paracetamol and diclofenac. Most suspected drugs were administered orally (98.4%). According to WHO–UMC causality assessment, 86.6% of ADRs were classified as probable and 13.4% as possible. Most reactions were non-serious (93.7%), and the majority of patients were recovering or had recovered following withdrawal of the suspected drug.

Conclusion

Fixed drug eruption was the most common CADR observed in the study, with antimicrobials and non-steroidal anti-inflammatory drugs being the major causative agents. Most reactions were non-serious and showed favourable outcomes after prompt withdrawal of the offending drug. Strengthening pharmacovigilance activities and increasing awareness regarding early recognition and reporting of CADRs can significantly improve patient safety and rational drug use.

Zitieren

APA

Atray, M., Mody, A. S., & Mehta, V. (2026). Pattern of Cutaneous Adverse Drug Reactions reported at a Tertiary Care Hospital in Southern Rajasthan: A Descriptive Study. International Journal of Pharmaceutical Quality Assurance, 17(06). https://doi.org/10.25258/ijpqa.17.6.29

Vancouver

Atray M, Mody AS, Mehta V. Pattern of Cutaneous Adverse Drug Reactions reported at a Tertiary Care Hospital in Southern Rajasthan: A Descriptive Study. International Journal of Pharmaceutical Quality Assurance. 2026;17(06). doi:10.25258/ijpqa.17.6.29

BibTeX
@article{Atray2026,
  author = {Atray, Meena and Mody, Arjun Sanjaykumar and Mehta, Vishwa},
  title = {Pattern of Cutaneous Adverse Drug Reactions reported at a Tertiary Care Hospital in Southern Rajasthan: A Descriptive Study},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {17},
  number = {06},
  doi = {10.25258/ijpqa.17.6.29}
}
Kostenlos starten →